Results 171 to 180 of about 726,956 (307)

Cognitive and Patient-Reported Outcome Measures in LGI-1-IgG Autoimmune Encephalitis. [PDF]

Ann Clin Transl Neurol
Ongphichetmetha T, Swetlik C, Thompson N, Aboseif A, Punia V, Lapin B, Cohen JA, Galioto R, Kunchok A.   +8 more
europepmc   +1 more source

Cross-cultural Validation of a Disease-specific Patient-reported Outcome Measure for Systemic Lupus Erythematosus in Canada [PDF]

, 2013
Josiane Bourré‐Tessier, Ann E. Clarke, Rachel A. Mikolaitis-Preuss, Mark Kosinski, Sasha Bernatsky, Joel A. Block, Meenakshi Jolly   +6 more
openalex   +1 more source

YAP1::TFE3 mediates endothelial‐to‐mesenchymal plasticity in epithelioid hemangioendothelioma

Molecular Oncology, EarlyView.
The YAP1::TFE3 fusion protein drives endothelial‐to‐mesenchymal transition (EndMT) plasticity, resulting in the loss of endothelial characteristics and gain of mesenchymal‐like properties, including resistance to anoikis, increased migratory capacity, and loss of contact growth inhibition in endothelial cells.
Ant Murphy, Samuel Hartzler, Paula A. Vargas Carranza, Shyaman Jayasundara, Madison E. Yates, Nimod D. Janson, Bozhi Liu, Annaleigh Benton, Majid Kazemian, Jason A. Hanna   +9 more
wiley   +1 more source

Patient-Reported Outcome Measures for Systemic Lupus Erythematosus Clinical Trials: A Content Validity and Psychometric Performance Review [PDF]

, 2013
L. Humphrey, Louise Heron, C. Pilling, Laura Holloway, Lise Højbjerre, Martin Strandberg-Larsen, B.B. Hansen   +6 more
openalex   +1 more source

Emerging role of ARHGAP29 in melanoma cell phenotype switching

Molecular Oncology, EarlyView.
This study gives first insights into the role of ARHGAP29 in malignant melanoma. ARHGAP29 was revealed to be connected to tumor cell plasticity, promoting a mesenchymal‐like, invasive phenotype and driving tumor progression. Further, it modulates cell spreading by influencing RhoA/ROCK signaling and affects SMAD2 activity. Rho GTPase‐activating protein
Beatrice Charlotte Tröster, Melanie Kappelmann‐Fenzl, Anja Katrin Bosserhoff, Nicole Rachinger   +3 more
wiley   +1 more source

Variations in quantifying patient reported outcome measures to estimate treatment effect. [PDF]

World J Methodol
Muthu S, Vadranapu S.
europepmc   +1 more source

Validation of the Crohn’s Life Impact Questionnaire (CLIQ), the First Patient-Reported Outcome Measure Specific to Adults with Crohn’s Disease [PDF]

, 2013
Jeanette Wilburn, Stephen P. McKenna, James Twiss, Karen Kemp, S. Campbell   +4 more
openalex   +1 more source

Tumor‐agnostic detection of circulating tumor DNA in patients with advanced pancreatic cancer using targeted DNA methylation sequencing and cell‐free DNA fragmentomics

Molecular Oncology, EarlyView.
We evaluated circulating tumor DNA (ctDNA) detection in advanced pancreatic cancer using DNA methylation, cell‐free DNA fragment lengths, and 5′ end motifs. Machine learning models were trained to estimate ctDNA levels from each feature and their combination.
Morten Lapin, Kjersti Tjensvoll, Karin Hestnes Edland, Satu Oltedal, Herish Garresori, Bjørnar Gilje, Saga Ekedal, Trygve Eftestøl, Jan Terje Kvaløy, Filip Janku, Oddmund Nordgård   +10 more
wiley   +1 more source

Choosing the Most Appropriate Patient-Reported Outcome Measures for Hand Function: A Guide for Pediatric Hand Surgeons. [PDF]

Hand (N Y)
Cordray H, Fiandeiro M, Struble SL, Vaile JR, Banala M, Pehnke M, Shah AS, Mendenhall SD.   +7 more
europepmc   +1 more source

Repeated Measure Analysis of Dermatitis Symptoms Evolution and Patient-Reported Outcome in N06C4: A Phase 3 Randomized Trial of Mometasone Furoate in Breast Cancer Patients Receiving Radiation Therapy [PDF]

, 2013
Terence T. Sio, Diane Schwartz, Philip J. Atherton, Michelle A. Neben Wittich, Patricia Griffin, James A. Martenson, Jeff A. Sloan, Roscoe F. Morton, Charles L. Loprinzi, Robert C. Miller   +9 more
openalex   +1 more source